Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

T Cell Receptor Sequencing

ABSTRACT: The T cell Receptor Sequencing dataset contains 84 files related to T cell receptor sequences obtained using ImmunoSeq by Adaptive Biotechnologies and phenotype metadata from 23 patients enrolled on a phase II clinical trial of neoadjuvant immune checkpoint blockade in high-risk resectable melanoma at MD Anderson Cancer Center (NCT02519322). Included are data on baseline and on-treatment samples from tumor and blood.

PROVIDER: EGAD00010001608 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

ff415fab-b9ee-4b34-a55f-d7f7045ed889 - samples

Project description:The Whole Exome Sequencing dataset contains 30 whole exome sequencing files (tumor, germ line DNA) and phenotype metadata for 15 patients on the phase II clinical trial of neoadjuvant immune checkpoint blockade in high-risk resectable melanoma at MD Anderson Cancer Center (NCT02519322). Included are data from baseline samples.

| EGAD00001004352 | EGA

Response and recurrence correlates in patients treated with neoadjuvant anti-PD-1 therapy for resectable oral-cavity squamous cell carcinoma

Project description:Neoadjuvant PD-1 blockade may be efficacious in patients with high-risk, resectable oral-cavity, head-and-neck cancer. To explore correlates of response patterns to neoadjuvant nivolumab treatment and post-surgical recurrences, we analyzed longitudinal tumor and blood samples in a cohort of 12 patients displaying 33% responsiveness. Pretreatment tumor-based detection of FLT4 mutations and PTEN signature enrichment favors response, and high tumor mutational burden improves recurrence-free survival. In contrast, preexisting and/or acquired mutations (in CDKN2A, YAP1, JAK2) correlate with innate resistance and/or tumor recurrence. Immunologically, tumor response after therapy entails T-cell receptor repertoire diversification in peripheral blood and intratumoral expansion of preexisting T-cell clones. A high ratio of regulatory to Th17 T cells in pretreatment blood predicts innate resistance, low cytolytic T-cell signature in pretreatment tumor, and low T-cell receptor repertoire diversity in pretreatment blood. Our study provides a molecular framework to advance neoadjuvant anti-PD-1 therapy for patients with resectable head-and-neck cancer.

2021-09-30 | GSE179730 | GEO

RNA-seq from human patient derived xenografts from pancreatic adenocarcinoma patients: RS10

Project description:RNA-seq from human PDX derived from radiographically resectable pancreatic adenocarcinoma patients. All surgically resected tumors were obtained after written patient consent and according to the institutional review board-approved protocols of the University of Texas M.D. Anderson Cancer Center.

2021-09-06 | E-MTAB-10116 | biostudies-arrayexpress

Gene expression profile at single cell level from the colorectal cancer (CRC)

Project description:This study is part of MD Anderson Cancer Center CRC Moon Shot. We used single cell RNAsequencing (scRNA-seq) to analyze the diversity of CRC.

2023-09-25 | GSE231559 | GEO

Rhesus Macaque Model of Mismatch Repair-Deficient Colorectal Cancer

Project description:This SuperSeries is composed of the SubSeries listed below. NIH grant(s): Grant ID: 5 P30 CA016672-44 Grant title: Cancer Center Support Grant Affiliation: The University of Texas MD Anderson Cancer Center Grantor: NCI

2022-03-31 | GSE178383 | GEO

Long-read RNA Sequencing of Human Meningiomas

Project description:We report long-read Iso-Seq data of 84 meningiomas, which are used to differentiate patients with several metadata characteristics.

2025-06-25 | GSE300855 | GEO

The MD Anderson Colorectal Cancer Case Control Study

Project description:The MD Anderson Colorectal Cancer Case Control Study

| PRJNA779120 | ENA

The MD Anderson Cutaneous Melanoma Case Control Study

Project description:The MD Anderson Cutaneous Melanoma Case Control Study

| PRJNA1076660 | ENA

The MD Anderson Cutaneous Melanoma Case Control Study

Project description:The MD Anderson Cutaneous Melanoma Case Control Study

| PRJNA1076661 | ENA

The MD Anderson Colorectal Cancer Case Control Study

Project description:The MD Anderson Colorectal Cancer Case Control Study